User: TahirAmin Topic: IP
Category: patent-legal-regime :: india
Last updated: Mar 23 2017 13:52 IST RSS 2.0
 
1 to 20 of 3,353    
`India–EFTA trade talks may adversely impact access to medicines in developing countries' 23.3.2017 TOI: India
Also found in: [+]
US needs highly skilled workers to keep innovating: Victoria A Espinel, Business Software Alliance 21.3.2017 ET: Opinion
We as an industry have more jobs that we can fill, we need to have high skilled workers in United States and we need to also welcome high skilled workers from other countries, said Victoria A Espinel.
Also found in: [+]
Now, even Indian lawyers bank on Artificial Intelligence 21.3.2017 Rediff: Business
With the demand for lower costs in process driven activities and a move away from the high rate, billable hours of legal services, AI platforms are being used internationally in many legal tasks.
Also found in: [+]
Protecting intellectual property or monopoly profits? 19.3.2017 Deccan Herald - Analysis
The Global Intellectual Property Centre of the US Chamber of Commerce has come out with an International Index of Intellectual Property. It shows India third from the bottom. The report has noted: "India's score is unchanged as patent protection remains outside of international best practices..."; "All countries should look at the index and incorporate the infinite possibilities to improve their IP environment and encourage that the next greatest innovation takes place on their soil"; "The Indian government's rhetoric to improve IP environment was yet to translate into action." Is this cause for worry, as the report and the newspapers seem to imply? When an index for ranking is constructed, it is always for a purpose. This was exemplified by the United Nations Development Programme's (UNDP) Index of Human Development, which highlighted the fact that growth did not necessarily correlate with positive changes in wellbeing represented by education, health and income. It did not 'trickle down'. The rankings ...
Also found in: [+]
U.S. trade nominee for ‘aggressive’ steps on IP 16.3.2017 Hindu: Business
IPRs have been a bone of contention between U.S., India
Also found in: [+]
Indian drug makers can export patented meds for approval: Delhi High Court 8.3.2017 ET: Pharma
Natco and Alembic, however, were directed to undertake that during the life of the respective patent, they will not export the respective patented invention for purposes other than those specified in section 107A.
Also found in: [+]
Delhi HC rules in favour of Indian pharma manufacturers Natco and Alembic 8.3.2017 All Companies Stories
The Delhi High Court on Wednesday allowed Indian drug manufacturers Natco Pharma and Alembic Pharmaceuticals to export Sorafinat and Rivaroxiban, generics of German pharma major Bayer's own cancer and blood thinning medicines. Bayer had initiated proceedings against the two Indian pharma companies to stop them from exporting the drug, which the defendants had claimed were being exported for purposes of experimentation and generation of valuable clinical trial data. Bayer had opposed this stance and argued that such exports did not meet the exceptions to patent infringement provided under Section 107A of the Indian Patents Act, 1970, as they violated conditions of compulsory licenses (Natco) and exceeded reasonable quantities (Alembic). Bayer had claimed that under the compulsory license provided to Natco, the company could only sell Sorafinat within India and that Alembic could not take benefit of the exception as they had exported over 90 kilograms of Rivaroxiban, worth around Rs 3 .
Also found in: [+]
Delhi High Court favours Natco, Alembic; allows them to export generics of Bayer's drugs 8.3.2017 ET: Pharma
Bayer had approached court in 2016 to stop Alembic Pharmaceuticals from exporting its generic of the German company's blood thinner brand 'Xarelto' (Rivaroxaban), used to prevent and treat dangerous blood clots.
Also found in: [+]
Pharma lobby cries foul on GIPC’s poor ranking to India 3.3.2017 ET: Pharma
Global Intellectual Property Centre (GIPC) index on intellectual property (IP) standards once again places India at the bottom of 45 countries.
Also found in: [+]
China is the world's principal IP infringer: US watchdog 27.2.2017 Latest News
Software piracy and theft of trade secrets cost the US economy as high as $600 billion a year
Also found in: [+]
How AI may become a game-changer for the Indian legal industry 18.2.2017 All Current Affairs Stories
AI systems are also being used for litigations involving US federal patent cases with great success
Also found in: [+]
Time to Break in India 15.2.2017 Hindu: Op-Ed
There is no point in hitching our bandwagon to what will soon be an obsolete patent game. We must think through alternative innovation incentives such as prizes and open source formats
Also found in: [+]
Healthcare and patient groups oppose patents on crucial hepatitis C drugs 15.2.2017 TOI: India
Also found in: [+]
USTR urged not to demand excessive IP enforcement in India 14.2.2017 ET: Infotech
MSF said countries should not be penalised or discouraged from making use of the public health safeguards that are intended to protect access.
Also found in: [+]
USTR urged not to demand excessive IP enforcement in India 14.2.2017 DNA: Health
Highlighting India's important role in manufacturing lifesaving medicines, an international medical humanitarian organisation today urged the US Trade Representative (USTR) to refrain from demanding excessive IP enforcement measures in India that undermine public health.
Also found in: [+]
US pharma sector demands keeping India in patent violator list 14.2.2017 ET: Pharma
PhRMA in a submission requested US Trade Representative (USTR) to continue to keep India on the Priority Watch List in the 2017 Special 301 Report.
Also found in: [+]
Domestic drug makers ask US to remove India from IP watch list 10.2.2017 Latest News
Pharma body moves USTR, says no cases of compulsory licensing or patent revocation in last two years
Also found in: [+]
TPP is dead, but its legacy lives on 9.2.2017 Hindu: Home
The Trans-Pacific Partnership was dead long before Donald Trump signed his executive order. But its damaging aspects, like stringent IP provisions, have just migrated to other agreements
Also found in: [+]
Intellectual Property index: India remains near bottom 9.2.2017 Hindu: Home
India remains near the bottom in an international Intellectual Property (IP) index by being ranked 43rd out of 45 countries, according to a report by the U.S. Chamber of Commerce’s Global Intellectua...
Also found in: [+]
India 43rd among 45 in Intelluctual Property index 8.2.2017 deccanherald.com
India continues to languish near the bottom in an international intellectual property index, ranking 43rd out of 45 global economies, according to a report by the US Chamber of Commerces Global Intellectual Property Center (GIPC). The GIPC also highlighted the need for the government to "build upon the positive rhetoric of its IPR policy with the substantial legislative reforms that innovators need". This is the fifth year in a row that India has been ranked at the bottom of the pack in the index. However, the 2017 report, titled 'The Roots of Innovation', represents a slight improvement in its performance as the country was ranked last or next-to-last in the last four years. "In India, many of the same challenges to innovation remain. Although it has made incremental progress, the government needs to build upon the positive rhetoric of its IPR policy with the substantial legislative reforms that innovators need," David Hirschmann, President and CEO of GIPC, said in a statement. "If Indian policymakers ...
Also found in: [+]
1 to 20 of 3,353